Vice president of Finance to assume duties until a replacement is found.
IRIDEX Corporation announced that Chief Financial Officer Atabak Mokari has left the Ccmpany for a senior finance executive role at another company. IRIDEX currently is searching for a replacement.
“We would like to thank Atabak for his service throughout the significant transformation of our business into the glaucoma treatment market,” said William M. Moore, chairman and CEO. “With a high level of professionalism and dedication, he led us through multiple capital raises and assisted in the transition of our organization. We wish him well in his next endeavor. As we identify a replacement, Romeo Dizon, vice president of Finance will be assuming responsibility for financial controls and reporting. During his tenure with the company, he has previously stepped successfully into this role before and we are very confident in his abilities.”
"The motivated and talented team at IRIDEX has been a pleasure to work with," said Atabak Mokari, Chief Financial Officer. "I am proud of our accomplishments over the last few years. The opportunity in glaucoma continues to grow and I am confident the Company is well positioned to further penetrate and make inroads throughout the glaucoma treatment continuum."
IRIDEX reiterates its full-year 2018 guidance range for G6 systems, probes and total revenue. The company expects G6 system shipments of 430 to 450, G6 probe shipments of 44,000 to 46,000 and total revenue of $41 million to $42 million.
IRIDEX Corporation develops, manufactures, and markets versatile laser-based medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company’s proprietary MicroPulse technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. IRIDEX’s current product line is used for the treatment of glaucoma, diabetic macular edema (DME) and other retinal diseases. IRIDEX’s products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. IRIDEX is headquartered in Mountain View, Calif.